StonvexLoading…
StonvexCore line items from ADAM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $45.74M | $172.06M | $601.95M | $431.27M | $270.64M |
Operating Income | Not available | $86.72M | $137.80M | $81.48M | $41.99M |
Net Income | Not available | $48.60M | $149.05M | $95.52M | $50.70M |
EPS (Diluted) | $0.18 | $0.40 | $1.10 | $0.65 | $0.29 |
Total Assets | Not available | $12.79B | $12.64B | $12.40B | $10.55B |
Total Liabilities | Not available | $11.33B | $11.21B | $11.00B | $9.16B |
Cash & Equivalents | Not available | $208.91M | $210.33M | $185.28M | $160.45M |
Free Cash Flow OCF − CapEx | Not available | Not available | $125.89M | Not available | Not available |
Shares Outstanding | Not available | 89.86M | 90.30M | 90.31M | 90.31M |